Open AccessIn vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents
Author(s) -
Vincent I. Ahonkhai,
Charles E. Cherubin,
Marcelino F. Sierra,
V. Bokkenheuser,
Michael A. Shulman,
Anne C. Mosenthal
Publication year - 1981
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.20.6.850
Subject(s) - cefoperazone , thienamycin , antimicrobial , microbiology and biotechnology , campylobacter fetus , cefotaxime , broth microdilution , moxalactam , campylobacter jejuni , chemistry , antibiotics , imipenem , biology , minimum inhibitory concentration , bacteria , antibiotic resistance , genetics
The activities of 11 antimicrobial agents against 36 strains of Campylobacter fetus subsp. jejuni were studied by a broth microdilution method. All strains were susceptible to 7 of the 11 antimicrobial agents. Of the newer agents tested N-formimidoyl thienamycin (MK0787) and rosaramicin had very good activity, whereas cefotaxime, moxalactam, and cefoperazone had poorer activity.